Imperial College London

Jeff Eaton

Faculty of MedicineSchool of Public Health

Senior Lecturer in HIV Epidemiology
 
 
 
//

Contact

 

jeffrey.eaton

 
 
//

Location

 

Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Eaton:2017:cid/cix341,
author = {Eaton, JW and Johnson, CC and Gregson, S},
doi = {cid/cix341},
journal = {Clinical Infectious Diseases},
pages = {522--525},
title = {The cost of not re-testing: HIV misdiagnosis in the ART ‘test-and-offer’ era},
url = {http://dx.doi.org/10.1093/cid/cix341},
volume = {65},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - We compared estimated costs of retesting human immunodeficiency virus (HIV)-positive persons before antiretroviral therapy (ART) initiation to the costs of ART provision to misdiagnosed HIV-negative persons. Savings from averted unnecessary ART costs were greater than retesting costs within 1 year using assumptions representative of HIV testing performance in programmatic settings. Countries should implement re-testing before ART initiation.
AU - Eaton,JW
AU - Johnson,CC
AU - Gregson,S
DO - cid/cix341
EP - 525
PY - 2017///
SN - 1537-6591
SP - 522
TI - The cost of not re-testing: HIV misdiagnosis in the ART ‘test-and-offer’ era
T2 - Clinical Infectious Diseases
UR - http://dx.doi.org/10.1093/cid/cix341
UR - http://hdl.handle.net/10044/1/48246
VL - 65
ER -